http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109423515-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109423515-B |
| titleOfInvention | Gene markers for liver cancer detection and application thereof |
| abstract | The invention discloses a group of genetic markers for liver cancer detection and application thereof, and is particularly suitable for detection of early liver cancer and/or detection of AFP negative liver cancer. A group of liver cancer gene markers comprises an EP400 gene, an MAPK1IP1L gene, a NUFIP2 gene, a PHC3 gene, an RPS6KB1 gene and an STX7 gene. The invention has the advantages that: the gene marker of the invention is used for the screening diagnosis of liver cancer, has high sensitivity and strong specificity, is convenient to detect because the peripheral blood which is most easily collected clinically is taken as a detection sample, is suitable for the early diagnosis of liver cancer and the detection of AFP negative liver cancer patients, and has wide application prospect. |
| priorityDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.